Better Lithotripsy and Ureteroscopy Evaluation of Stenting (BLUES)

NACompletedINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

December 2, 2021

Primary Completion Date

July 1, 2024

Study Completion Date

August 21, 2024

Conditions
Renal StoneUreteral Stone
Interventions
DEVICE

Silicone (Coloplast Imajin Hydro) ureteral stent

During the end of the standard of care ureteroscopy the silicone stent will be placed.

DEVICE

Non-silicone (Polyurethane/Percuflex) ureteral stent (any manufacturer)

During the end of the standard of care ureteroscopy the Non-silicone (Polyurethane/Percuflex) stent will be placed.

Trial Locations (10)

48038

Henry Ford Macomb Hospital, Clinton Township

48073

William Beaumont Hospital (Michigan Institute of Urology), Royal Oak

48085

William Beaumont Hospital (Michigan Institute of Urology), Troy

48109

Michigan Medicine, Ann Arbor

48116

Michigan Medicine, Brighton

48118

Chelsea Hospital (Saint Joseph Mercy), Chelsea

48197

Integrated Healthcare Association (IHA) (Saint Joseph Mercy Hospital), Ypsilanti

48202

Henry Ford Hospital, Detroit

48322

Henry Ford West Bloomfield Hospital, West Bloomfield

48374

Ascension Hospital (Comprehensive Urology), Novi

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Coloplast A/S

INDUSTRY

lead

University of Michigan

OTHER

NCT05026710 - Better Lithotripsy and Ureteroscopy Evaluation of Stenting (BLUES) | Biotech Hunter | Biotech Hunter